Azenta Inc.
AZTA | NASDAQ
$34.05
+$0.30 (+0.89%)
Sep 22, 2026, 10:40 AM ET · Market open
Company Profile
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
Key Executives
| Name | Position |
|---|---|
| John Marotta | President, Chief Executive Officer & Director |
| Martin D. Madaus | Interim President, CEO & Director |
| Lawrence Y. Lin | Executive Vice President & Chief Financial Officer |
| Alex Esmon | Vice President and General Manager of Sample Repository Solutions |
| Andrea O'Hara | Strategic Technical Specialist of Azenta Life Sciences |
| Ephraim Starr | Senior Vice President, General Counsel & Corporate Secretary |
| Ginger Zhou | Advisor |
| Michael Paulo | Vice President, Chief Information & Digital Officer |
| Olga Pirogova | Senior Vice President & Chief HR Officer |
| William E. Martin | Senior Vice President & President of Multiomics |
| Yvonne Perron | Vice President of Financial Planning & Analysis and Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 04, 2026 | 8-K | Current Report |
| Aug 24, 2026 | 8-K | Current Report |
| Aug 11, 2026 | 4 | Filing |
| Aug 11, 2026 | 8-K | Current Report |
| Aug 06, 2026 | 10-Q | Quarterly Report |
| Aug 04, 2026 | 4 | Filing |
| Aug 04, 2026 | 8-K | Current Report |
| Jul 08, 2026 | 8-K | Current Report |
| May 26, 2026 | SD | Filing |
| May 19, 2026 | 4 | Filing |
Azenta Inc.
| Country | United States |
| IPO Date | Feb 1, 1995 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 2,900 |
| CEO | John Marotta |
Contact Details
200 Summit Drive Burlington,
Massachusetts 01803 United States
Stock Details
| Ticker Symbol | AZTA |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0000933974 |
| CUSIP Number | 114340102 |
| ISIN Number | US1143401024 |
| SIC Code | 3559 |
Recent News
- 5 days ago / prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
- 18 days ago / prnewswire.comAzenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical Systems
- 29 days ago / prnewswire.comAZENTA ANNOUNCES LEADERSHIP TRANSITION
- 1 month ago / seekingalpha.comAzenta: Needs To Overcome A Few Hurdles If The Rally Is To Continue
- 2 months ago / seekingalpha.comAzenta, Inc. (AZTA) Q3 2026 Earnings Call Transcript
- 2 months ago / marketbeat.comAzenta Q3 Earnings Call Highlights
- 2 months ago / prnewswire.comAzenta Reports Third Quarter Results for Fiscal 2026, Ended June 30, 2026.
- 2 months ago / prnewswire.comAzenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast
- 3 months ago / prnewswire.comAzenta Completes Sale of B Medical Systems
- 4 months ago / gurufocus.comAzenta Inc (AZTA) Stock Up 5.4% and Still Undervalued -- GF Score: 72/100
Add to Watchlist
Select watchlists to add or remove AZTA